0000899243-21-032385.txt : 20210810 0000899243-21-032385.hdr.sgml : 20210810 20210810181749 ACCESSION NUMBER: 0000899243-21-032385 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210806 FILED AS OF DATE: 20210810 DATE AS OF CHANGE: 20210810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Recknor Chris P CENTRAL INDEX KEY: 0001850917 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 211161372 MAIL ADDRESS: STREET 1: 1111 MAIN STREET STREET 2: SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-06 1 0001175680 CytoDyn Inc. CYDY 0001850917 Recknor Chris P 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 0 1 0 0 Chief Operating Officer Common stock 2021-08-06 4 A 0 19384 0.00 A 686050 D Non-qualified stock option (right to buy) 1.32 2021-08-06 4 A 0 1450000 0.00 A 2031-08-06 Common stock 1450000 1450000 D Represents shares received in lieu of 50% of a cash incentive bonus paid for services performed during the fiscal year ended May 31, 2021, which may be paid (a) 100% in cash or (b) 50% in stock and 50% in cash, as determined by the issuer's compensation committee of the board of directors. The option vests in three equal annual installments beginning on August 6, 2022. /s/ Antonio Migliarese, Attorney-in-fact 2021-08-10